EDMONTON – Aurora Cannabis Inc. has struck a friendly deal valued at $1.1 billion to buy rival licensed producer CanniMed Therapeutics Inc., bringing an end to a hostile takeover battle between the marijuana companies. Under the agreement, Aurora has agreed to pay $43 per share in stock and cash … Read More
The post Aurora Cannabis to buy CanniMed Therapeutics in friendly deal valued at $1.1B appeared first on Dagga Magazine.